Clinical trial IVF California
Getting pregnant using fertility treatments like in vitro fertilization is stressful for any couple. But for couples in which one or both partners has the potential of having a child with a genetically based disease like Tay Sachs or Gaucher’s disease can be frightening. A new genetic screening under clinical study gives at-risk IVF patients a fuller glimpse of their developing embryos.
Until now, IVF patients have had to choose between testing for chromosome abnormalities like Down Syndrome or single-gene hereditary disorders like Tay Sachs. A new screening from Redwood City, Calif. based Gene Security Network combines single gene hereditary disease testing and a 24-chromosome comparison into one test.
Dr. Ernest Zeringue, founder of California IVF: Davis Fertility Center, Inc. says “this test will offer at risk couples an additional tool for increasing their chance of pregnancy while minimizing the risk of having a baby with a genetic disorder.”
While new technology can not completely relieve the worries of getting pregnant, this next step in the genetic testing of embryos will help at risk patients make more informed decisions about their best options for bringing home a healthy baby.
The Patients Voice in HIV/AIDS Clinical Trial Participation: What motivates the willingness of HIV infected people to take part in HIV/AIDS clinical trials?
Book (LAP LAMBERT Academic Publishing)
Call to step up the pace of TB-HIV collaborative activities — Weekly Blitz
Discovery by biomedical research of new and improved interventions can get into the bucket of implementation.